Clik here to view.
CompuGroup ends Agfa courtship
German medical software company CompuGroup Medical has dropped its offer to pick up Belgian graphics group Agfa-Gevaert (EBR:AGFB), the companies said this week. Neither company offered any reason as...
View ArticleClik here to view.
Echo Therapeutics faces uncertain future in whistleblower case
Echo Therapeutics (NSDQ:ECTE) said today that it’s future may be in jeopardy after getting hit with a restrictive injunction related to a whistleblower case alleging securities violations, theft of...
View ArticleClik here to view.
B Braun announces collab deal with Omnicell
B. Braun said this week it inked a collaborative deal with Omnicell to help decrease the time and clinical support necessary to manage IV infusions and IV compounding. Through the deal, Omnicell will...
View ArticleClik here to view.
BioTelemetry pays $7m for Telecare Medical Supply
BioTelemetry (NSDQ:BEAT) said today it will pay $7 million in cash to pick up Telcare Medical Supply, which it said was the 1st company to receive FDA clearance for a cellular-enabled blood glucose...
View ArticleClik here to view.
FDA clears BrightWater Medical’s ConvertX nephroureteral stent
Ureteral medical device company BrightWater Medical said today it won FDA 510(k) clearance for its ConvertX nephroureteral stent system designed for treating ureteral obstructions. The ConvertX System...
View ArticleClik here to view.
Retractable Technologies plummets after appeals court tosses $352m win over...
Shares in Retractable Technologies (NYSE:RVP) lost nearly half their value last week after a federal appeals court overturned its $352 million anti-trust win over Becton Dickinson (NYSE:BDX). A 3-judge...
View ArticleClik here to view.
Combination products review program: Progress and potential
By: Nina L. Hunter, Ph.D., and Robert M. Califf, M.D. About a year ago, we shared with you our Combination Product Review, Intercenter Consult Process Study Report, which was developed by FDA’s Office...
View ArticleClik here to view.
GSK, Innoviva seek EU nod for triple combo inhaled therapy
GlaxoSmithKline (NYSE:GSK) and Innoviva (NSDQ:INVA) said last week that they filed a regulatory submission with the European Medicines Agency for the once-daily, triple-combination therapy fluticasone...
View ArticleClik here to view.
Lab-grown bone shows 100% success rate in small, early study
Israel’s Bonus Biogroup (TLV:BONS) said today that it successfully injected its lab-grown, semi-liquid bone graft into the jaws of 11 people in an early stage clinical trial evaluating bone loss...
View ArticleClik here to view.
Sunovion launches clinical trial for anti-epileptic drug with wearable tech
Sunovion Pharmaceuticals said today that it will soon begin enrollment for a Phase IV study of its anti-epileptic drug Aptiom with Empatica‘s Embrace watch. The Marlborough, Mass.-based company touted...
View ArticleClik here to view.
Data points to no age-related cutoff for mammogram screenings | RSNA 2016...
There is no clear cut-off age to stop breast cancer screening, according to new data from the largest-ever study on mammogram screening outcomes. Data from the study was presented this week at the...
View ArticleClik here to view.
InGeneron inks collaboration with German Accelerator Life Sciences
InGeneron said today that it landed a collaboration with the German Accelerator Life Sciences program, establishing an additional U.S. presence in Cambridge, Mass. The initiative is supported by the...
View ArticleClik here to view.
Scilex touts data for novel lidocaine patch
Sorrento Therapeutics (NSDQ:SRNE) subsidiary Scilex Pharmaceuticals said today that its lidocaine patch, ZTlido, met primary and secondary endpoints in a pivotal study comparing the patch to Endo...
View ArticleClik here to view.
Tricuspid repair firm 4Tech names Thoratec vet Ennen as CEO | Personnel Moves...
Transcatheter tricuspid heart valve repair device developer 4Tech said today it tapped former Thoratec interventional products GM Dr. Michael Ennen as its new prez & CEO, taking over for Carine...
View ArticleClik here to view.
Biotronik launches BioMonitor 2 subcutaneous heart monitor trial
Biotronik said today it enrolled the 1st patients in the BioInsight clinical study of its BioMonitor 2 heart monitor, which looks to investigate the feasibility implanting the BioMonitor 2 in office...
View ArticleClik here to view.
NeuroPace touts 7-year data on RNS neurostim therapy for epilepsy
NeuroPace today released 7-year follow-up data from a clinical trial of its RNS neurostimulation system designed to prevent epileptic seizures, touting an over-70% reduction in seizure frequency. The...
View ArticleClik here to view.
MassDevice.com +5 | The top 5 medtech stories for December 5, 2016
Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s...
View ArticleClik here to view.
FDA clears Kyocera Medical’s Initia hip implant
Implantable medical systems maker Kyocera Medical said today it won FDA 510(k) clearance for its Initia total hip implant system. The Japanese company’s Initia total hip system includes Bioceram Azul...
View ArticleClik here to view.
Researchers show drug, catheter combo speeds up labor delivery
Using the drug misoprostol in combination with a Foley balloon catheter to induce labor can lead to a speedier delivery, with women delivering several hours earlier than either method alone, according...
View ArticleClik here to view.
Usnic acid electrospun fibers demonstrate antibacterial properties
Researchers from the Institute of Materials Science in Juazeiro, Brazil have reported on the antibacterial properties of usnic acid, a strong lichen metabolite, encapsulated in electrospun fibers. The...
View Article
